92
Views
31
CrossRef citations to date
0
Altmetric
Review

Marine natural products as therapeutic agents: Part 2

, &
Pages 17-33 | Published online: 02 Mar 2005

Bibliography

  • KERR RG, KERR SS: Marine natural products as therapeutic agents. Expert Opin. Ther. Patents (1999) 9:1207–1222.
  • ••Previous review in this series.
  • JONES RM, CARTIER G, EDWARD MJ et al.: Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996–2000. Expert Opin. The]: Patents (2001) 11:603–623.
  • KELECOM A: Secondary metabolites from marine organisms. Anais da Academia Brasileira de Ciencias. (2002) 74:151–170.
  • •An in-depth review.
  • MAIESE WM, LECHEVALIER MP, LECHEVALIER HA et al: LL-E19085 a, a novel antibiotic from Micromonospora citrea: taxonomy, fermentation and biological activity. J. Antibiot. (1989) 42:846–851.
  • FAULKNER DJ: Marine natural products. Nat. Prod. Rep. (2002) 19:1–48.
  • •Most recent publication in a series of comprehensive reviews.
  • BLUNT JW, COPP BR, MUNRO MH, NORTHCOTE PT, PRINSEP MR: Marine natural products. Nat. Prod. Rep. (2003) 20:1–48.
  • •An in-depth review.
  • TEIXEIRA VL, KELECOM A, GOTTLIEB 0: Natural products of marine algae. Quim. Nova (1991) 14:83–90.
  • BURJA AM, BANAIGS B, ABOU-MANSOUR E, GRANT BURGESS J, WRIGHT PC: Marine cyanobacteria: a prolific source of natural products. Tetrahedron (2001) 57:9347–9377.
  • HARRIGAN GG, LUESCH H, YOSHIDA WY et al: Symplostatin 1: a dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides. I Nat. Prod (1998) 61:1075–1077.
  • PROTEAU PJ, GERWICK WH, GARCIA-PICHEL F, CASTENHOLZ R: The structure of scytonemin, an ultraviolet sunscreen pigment from the sheaths of cyanobacteria. Experientia (1993) 49:825–829.
  • STEVENSON CS, CAPPER EA, ROSHAK AK et al.: The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. Pharmacol. Exp. Ther. (2002) 303:858–866.
  • MURRAY LM, JOHNSON A, DIAZ MC, CREWS P: Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitors. .1 Org. Chem. (1997) 62:5638–5641.
  • DAVIES-COLEMAN MT, FAULKNER DJ, DUB OWCHIK GM,ROTH GP, POLSON C, FAIRCHILD C: A new EGF-active polymeric pyridinium alkaloid from the sponge Calyspongia fibrosa. I Org. Chem. (1993) 58:5925.
  • LINDEL T, JENSEN PR, FENICAL W et al.: Eleutherobin, a new cytotoxin that mimics paclitaxel (Taxol) by stabilizing microtubules. J. Amer. Chem. Soc. (1997) 119:8744–8745.
  • MITTA G, HUBERT F, NOEL T, ROCH P: Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis. Ear: I Biochem. (1999) 265:71–78.
  • PROSTENIK M, ALAUPOVIC P: Application of the asymmetric synthesis in the determination of the configuration of amino alcohols and diamines with two adjacent asymmetric carbon atoms. Croat. Chem. Acta (1957) 29:393–402.
  • TWELVES C, HOEKMAN K, BOWMAN A et al.: Phase I and pharmacokinetic study of YondelisTm (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. Ear: Cancer (2003) 39: 842-1851.
  • BAKER MA, GRUBB DR, LAWEN A. Didemnin B induces apoptosis in proliferating but not resting peripheral blood mononuclear cells. Apoptosis (2002) 7:407–412.
  • BONGIORNI L, PIETRA F: Marine natural products for industrial applications. Chem. Ind. London (1996) 2:54–58.
  • ••First review of the marine natural productspatent literature.
  • PROKSCH P, EDRADA RA, EBEL R: Drugs from the seas - current status and microbiological implications. Appl. Microb. Blot. (2002) 59:125–134.
  • KELECOM A: Secondary metabolites from marine microorganisms. An. Acad. Bras. Cienc. (2002) 74:151–170.
  • MYDLARZ L, JACOBS RS, BOEHNLEIN J, KERR RG: Pseudopterosin biosynthesis in Symbiodinium sp., the dinoflagellate symbiont of Pseudopterogorgia elisabethae Chem. Biol. (2003) 10(11):1051–1056.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.